TIAA CREF Investment Management’s Novartis NVS Stock Holding History

TIAA CREF Investment Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$12.9M	Buy	+150,242	New	+$12.1M	0.01%	908
2015 Q3	–	Sell	-264,048	Closed	-$23.3M	–	3126
2015 Q2	$23.3M	Sell	264,048 -502,538	-66%	-$46.1M	0.02%	733
2015 Q1	$67.7M	Buy	+766,586	New	+$68M	0.05%	405
2014 Q4	–	Sell	-140,827	Closed	-$11.9M	–	3152
2014 Q3	$11.9M	Sell	140,827 -61,171	-30%	-$4.95M	0.01%	993
2014 Q2	$16.4M	Sell	201,998 -36,202	-15%	-$2.85M	0.01%	868
2014 Q1	$18.1M	Sell	238,200 -1,324,886	-85%	-$96.5M	0.01%	827
2013 Q4	$113M	Buy	1,563,086 +849,628	+119%	+$59.1M	0.08%	268
2013 Q3	$49M	Buy	713,458 +206,436	+41%	+$13.7M	0.04%	477
2013 Q2	$32.1M	Buy	+507,022	New	+$33M	0.03%	575

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

TIAA CREF Investment Management's NVS Position: Q1 2019 in Review

TIAA CREF Investment Management opened a new position in Novartis (NVS) in Q1 2019: 150,242 shares worth $12.9M. The stake represents 0.01% of the portfolio and ranks #908 among its holdings. This is a return to the name: TIAA CREF Investment Management previously reported a position in NVS as recently as Q2 2015.

TIAA CREF Investment Management first reported a position in NVS in Q2 2013 and has held it in 9 quarters since. The position peaked at $113M in Q4 2013. 1,133 funds tracked by Wall St. Rank hold NVS as of Q1 2019.

TIAA CREF Investment Management held 150,242 shares of Novartis worth $12.9M as of Q1 2019.
Novartis was a new TIAA CREF Investment Management position in Q1 2019.
Novartis made up 0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #908 holding.
TIAA CREF Investment Management first reported a position in Novartis in Q2 2013 and has held it in 9 quarters since.
TIAA CREF Investment Management's Novartis position peaked at $113M in Q4 2013.
1,133 funds tracked by Wall St. Rank held Novartis as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.